Report cover image

United States (US) Generics Market Summary, Competitive Analysis and Forecast to 2027

Publisher MarketLine
Published Jul 21, 2023
Length 45 Pages
SKU # MTLN18195741

Description

United States (US) Generics Market Summary, Competitive Analysis and Forecast to 2027


Summary

Generics in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
  • The US generics market had total revenues of $69.9 billion in 2022, representing a compound annual growth rate (CAGR) of 2.2% between 2017 and 2022.
  • Market consumption volume increased with a CAGR of 0.3% between 2017 and 2022, to reach a total of 91.4 % in 2022.
  • 9 out of 10 prescriptions written in the United States, according to the FDA, are for generic drugs. Increased access to generic drugs encourages market competition, which lowers the cost of treatment and broadens access to healthcare for more patients.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in the United States
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in the United States
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the United States generics market with five year forecasts
Reasons to Buy
  • What was the size of the United States generics market by value in 2022?
  • What will be the size of the United States generics market in 2027?
  • What factors are affecting the strength of competition in the United States generics market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the United States's generics market?

Table of Contents

45 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Have there been any recent developments in the market?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. Pfizer Inc.
8.4. Novartis AG
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: United States generics market value: $ million, 2017-22
Table 2: United States generics market volume: %, 2017-22
Table 3: United States generics market geography segmentation: $ million, 2022
Table 4: United States generics market value forecast: $ million, 2022-27
Table 5: United States generics market volume forecast: %, 2022-27
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Viatris Inc.: key facts
Table 10: Viatris Inc.: Annual Financial Ratios
Table 11: Viatris Inc.: Key Employees
Table 12: Viatris Inc.: Key Employees Continued
Table 13: Pfizer Inc.: key facts
Table 14: Pfizer Inc.: Annual Financial Ratios
Table 15: Pfizer Inc.: Key Employees
Table 16: Pfizer Inc.: Key Employees Continued
Table 17: Novartis AG: key facts
Table 18: Novartis AG: Annual Financial Ratios
Table 19: Novartis AG: Key Employees
Table 20: Novartis AG: Key Employees Continued
Table 21: United States size of population (million), 2018-22
Table 22: United States gdp (constant 2005 prices, $ billion), 2018-22
Table 23: United States gdp (current prices, $ billion), 2018-22
Table 24: United States inflation, 2018-22
Table 25: United States consumer price index (absolute), 2018-22
Table 26: United States exchange rate, 2018-22
List of Figures
Figure 1: United States generics market value: $ million, 2017-22
Figure 2: United States generics market volume: %, 2017-22
Figure 3: United States generics market geography segmentation: % share, by value, 2022
Figure 4: United States generics market value forecast: $ million, 2022-27
Figure 5: United States generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in the United States, 2022
Figure 7: Drivers of buyer power in the generics market in the United States, 2022
Figure 8: Drivers of supplier power in the generics market in the United States, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in the United States, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in the United States, 2022
Figure 11: Drivers of degree of rivalry in the generics market in the United States, 2022

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us